William Woods, a retired doctor in Atlanta who has ALS, says he needs to go to Canada for Albrioza ‘sooner rather than later’ because of the disease’s relentless progression.Updated June 22, 2022 5:55 pm ET
Canada approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis last week. Now some U.S. patients with the fatal neurodegenerative disorder—also known as Lou Gehrig’s disease—are considering a trip north to get the medication, Albrioza. The drugWilliam Woods, a 75-year-old retired doctor in Atlanta who was diagnosed with ALS in 2019, is contacting Canadian doctors who might help him get Albrioza.
They won’t approve a drug for people on their last legs but happily approve a experimental vaccine for toddlers who don’t need it. It has to be a money issue. The ALS drug is obviously a money loser.
America the great where medical tourism for procedures and meds is a thing. Cheaper to fly over, stay, get TX and come back than to sit here dying to get partial if anything covered by insurance for life extending or saving procedure.
Risking a trip to Canada is almost like going to North Korea based on the recent Prime Ministers actions. But the food is more interesting in North Korea.